Henry Ford Health research teams are launching a series of clinical studies in partnership with Illumina Inc., a global leader in DNA sequencing and array-based technologies, to assess the impact of comprehensive genomic testing in various disease areas.
/PRNewswire/ Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics company,.
NORTHAMPTON, MA / ACCESSWIRE / February 3, 2023 / IlluminaOriginally published on Illumina News CenterAccording to the World Health Organization, half the world's population does not have access to essential
Illumina Debuts Metagenomics Research Test Kit - San Diego Business Journal sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics company,.